• Direct Mouse Genotyping Kit Plus for Phenotype Studies

  2026-09-01

  The Direct Mouse Genotyping Kit Plus connects rapid mouse tissue lysis with high-fidelity PCR for better genotype-to-phenotype study design. This guide explains how direct PCR can support SCA3 mouse research while preserving the distinction between genetic inclusion criteria and downstream molecular endpoints.

• Cy5-UTP: From RNA Labeling to Condensate Biology

  2026-09-01

  Cy5-UTP enables direct fluorescent RNA labeling while preserving a path from probe synthesis to mechanistic analysis. This article examines how Cyanine 5-uridine triphosphate can support FISH, multicolor assays, and RNA–protein condensate studies, using the U3 snoRNA–DDX21 system as a practical case study.

• Anti Reverse Cap Analog: mRNA Workflow

  2026-08-31

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, enables orientation-specific Cap 0 formation for higher-confidence synthetic mRNA expression. This workflow connects cap selection and quality control with targeted nanoparticle studies, including the IL-10 mRNA strategy reported for postischemic stroke research.

• Clozapine: A Causal Assay Framework for Schizophrenia

  2026-08-31

  Clozapine is more than an atypical antipsychotic medication benchmark: it can anchor a layered assay strategy linking receptor pharmacology, ERK1/2 signaling activation, hepatotoxicity studies, and prefrontal-circuit research. This article interprets a recent magnetic-stimulation study to show how pharmacological, genetic, and circuit-level evidence can be integrated without conflating mechanisms.

• Cy5-UTP RNA Labeling for FISH and RNA Probes

  2026-08-30

  Cy5-UTP enables direct, far-red visualization of RNA made by T7 in vitro transcription, supporting FISH, multiplex imaging, and dual-color expression arrays. This guide translates the chemistry into practical probe-synthesis, assay-design, and troubleshooting decisions, including a careful extension to SARS-CoV-2 stress-granule research.

• Trelagliptin succinate: RUNX2 Assay Guide

  2026-08-29

  Translate DPP-4 enzyme inhibition into reproducible diabetes, osteoblast, and bone-metabolism experiments with Trelagliptin succinate (SYR-472 succinate). This workflow combines dose planning, AMPK–RUNX2 pathway validation, mineralization readouts, and troubleshooting for cell-based studies.

• WP1066: JAK2/STAT3 Inhibitor Workflows

  2026-08-28

  WP1066 provides a cell-permeable way to test JAK2/STAT3 dependence in cancer cells, AML models, and exploratory macrophage assays. This guide connects dose-response design, pathway validation, proliferation measurements, and the signaling insights of a recent infectious bone-regeneration study.

• Anti Reverse Cap Analog for High-Expression mRNA

  2026-08-28

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, helps researchers produce orientation-controlled capped mRNA for stronger translation in cell, gene-editing, reprogramming, and nanoparticle workflows. This practical guide connects cap selection with the targeted mRNA nanoparticle strategy reported in ischemic-stroke research while separating demonstrated evidence from assay recommendations.

• TMEM16F in Kupffer Cells Protects Against Listeria

  2026-08-27

  This study identifies Kupffer cell-expressed TMEM16F, rather than TMEM16F in T or B cells, as a critical determinant of protection against Listeria monocytogenes. Its findings connect calcium-activated lipid scrambling and plasma-membrane repair with control of liver inflammation, tissue injury, and metabolic disruption.

• TRPM3 Modulation by Neurosteroids and Primidone

  2026-08-27

  Yin and colleagues combine cryo-electron microscopy, electrophysiology, molecular dynamics, and biochemical analyses to define how pregnenolone sulfate, CIM 0216, and primidone regulate TRPM3. The ligand-bound structures connect channel pharmacology with pain signaling and TRPM3-linked neurodevelopmental disease, providing a framework for interpreting mutations and designing selective modulators.

• Chloroquine Workflows for Autophagy Research

  2026-08-26

  Chloroquine is a practical tool for testing lysosomal function, autophagic flux, inflammatory signaling, and combination-treatment responses. This workflow-centered guide helps researchers select concentrations, separate autophagy-dependent from independent effects, and troubleshoot ambiguous results.

• 5-Methyl-CTP for Modified mRNA Synthesis

  2026-08-26

  5-Methyl-CTP is a 5-methyl modified cytidine triphosphate for in vitro transcription of chemically modified mRNA. It is a research reagent intended to support enhanced mRNA stability and improved mRNA translation efficiency, but its performance depends on polymerase compatibility, transcript design, purification, and delivery.

• Bobcat339 and the Epigenetic Logic of Osteogenesis

  2026-08-25

  A translational framework for using Bobcat339 to dissect TET-dependent DNA demethylation, super-enhancer redistribution, and osteogenic failure in senile osteoporosis models.

• T7 RNA Polymerase and the RNA Stability Frontier

  2026-08-25

  How T7 RNA Polymerase can help translational researchers convert the DDX21–SIRT7–NAT10–ac4C mechanism in colorectal cancer into controlled RNA assays, while preserving a clear boundary between experimental enablement and therapeutic evidence.

• CBD, Endocannabinoid Signaling, and Orofacial Pain

  2026-08-24

  This 2026 study shows that cannabidiol reduces acute orofacial inflammatory pain while also improving anxiety-like, depression-like, and cognitive deficits in mouse models. Its main contribution is a mechanistic distinction between peripheral CB2-linked effects and central CB1-linked modulation of endocannabinoid, inflammatory, oxidative, and serotonergic pathways.

581 records 8/39 page Previous Next First page 上5页 678910 下5页 Last page